Private Equity
1 min read · 02 January 2010
Artifact, operator of an online auction marketplace, has merged with Auctionzip, a directory of live auction listings. The combined company also announced that it has raised $13 million in VC funding from Commonwealth Capital Ventures and Ascent Venture Partners.
2 min read · 28 December 2009
1 min read · 24 December 2009
LifeSync Holdings Inc. has purchased the Besson wireless patent portfolio from Motorola Inc. No financial terms were disclosed. The patents cover "wireless, two-way, digital communication between patient-electrodes or sensors and an evaluator station for monitoring a patient." LifeSync is a subsidiary of GMP Companies, whose investors include Affinity Capital Management, TPG Captial and VCE Capital.
1 min read · 23 December 2009
Deltagen Inc. (OTC BB: DGEN) has acquired Benten BioServices Inc., a provider of manufacturing and testing services for the pharma development market. As part of the deal, Penn Venture Partners and Life Sciences Greenhouse invested approximately $1.5 million in the combined company.
5 min read · 22 December 2009
3 min read · 22 December 2009
Ambit Biosciences and Astellas Pharma have agreed to jointly develop and commercialize FLT3 kinase inhibitors in oncology and non-oncology indications. Under the terms of the agreement, Ambit will receive an up-front cash payment of $40 million and will be eligible to receive pre-commercialization payments of up to $350 million. San Diego-based Ambit has raised over $100 million in VC funding, from MedImmune Ventures, OrbiMed Advisors, Radius Ventures, NovaQuest, Horizon Technology Finance, Perseus-Soros Biopharmaceutical Fund, Forward Ventures, Avalon Ventures, Roche Venture Fund, GIMV, Jov-CMDF and Genechem.
5 min read · 21 December 2009
Durata Therapeutics Inc., an antibiotic development platform recently formed by five venture capital firms, has acquired Vicuron Pharmaceuticals, developer of an antibiotic drug candidate called dalbavancin, from Pfizer. No financial terms were disclosed. Durata's backers are New Leaf Venture Partners, Domain Associates, Aisling Capital, Sofinnova Ventures and Canaan Partners.
2 min read · 21 December 2009
1 min read · 18 December 2009
2 min read · 18 December 2009
